| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8815187 | Journal of Affective Disorders | 2018 | 5 Pages |
Abstract
Results of this study indicated no increased risk for cardiovascular disorders during treatment with supraphysiologic L-T4 doses in patients with refractory mood disorders.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Maximilian Pilhatsch, Anne Berghöfer, René Mayer-Pelinski, Gunnar Berghöfer, Roland Ricken, Martin Möckel, York Kühnle, Cathrin Sauer, Peter C. Whybrow, Michael Bauer,